Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Exchange Rate Effect (2023 - 2025)

Neurocrine Biosciences (NBIX) has disclosed Exchange Rate Effect for 3 consecutive years, with -$200000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Exchange Rate Effect fell 166.67% year-over-year to -$200000.0, compared with a TTM value of -$200000.0 through Dec 2025, changed N/A, and an annual FY2023 reading of $300000.0, up 123.08% over the prior year.
  • Exchange Rate Effect was -$200000.0 for Q3 2025 at Neurocrine Biosciences, up from -$300000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $300000.0 in Q4 2023 and bottomed at -$300000.0 in Q4 2024.
  • Average Exchange Rate Effect over 3 years is $25000.0, with a median of $50000.0 recorded in 2023.
  • The sharpest move saw Exchange Rate Effect plummeted 200.0% in 2024, then crashed 166.67% in 2025.
  • Year by year, Exchange Rate Effect stood at $300000.0 in 2023, then tumbled by 200.0% to -$300000.0 in 2024, then soared by 33.33% to -$200000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for NBIX at -$200000.0 in Q3 2025, -$300000.0 in Q4 2024, and $300000.0 in Q3 2024.